Evidence map›Paper›PMID 41820508›Full record

ArticleScientific reports2026

Topology constrained nonnegative matrix factorization for time varying omic expression.

Anirban Dey, Kaushik Das Sharma, Amitava Chatterjee, Pritha Bhattacharjee

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anirban DeyInstitute of Technical Education & Research, Siksha 'O' Anusandhan, Bhubaneswar, India. anirbandey@soa.ac.in.
Kaushik Das SharmaDepartment of Applied Physics, University of Calcutta, Kolkata, India.
Amitava ChatterjeeDepartment of Electrical Engineering, Jadavpur University, Kolkata, India.
Pritha BhattacharjeeDepartment of Environmental Science, University of Calcutta, Kolkata, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deciphering disease-specific progression from low sample size, high-dimensional omic profiles remains challenging. Traditional biomarker discovery methods are costly and limited, while Nonnegative Matrix Factorization (NMF), though popular, suffers from instability and lack of biologically relevant solutions. This study aims to overcome these limitations by introducing a more robust framework. This article proposes TopConNMF, a topology-constrained extension of NMF which incorporates structural constraints, ensures stability, accuracy, and faster performance while maintaining biological interpretability. The method was evaluated on two publicly available time-varying omic datasets with established ground truths and compared against other state-of-the-art approaches. The TopConNMF consistently demonstrated stable performance across both the datasets, delivering superior accuracy and biologically relevant factorization compared to conventional NMF and other benchmark methods. The exhaustive evaluation confirmed its robustness in capturing disease-specific profiles and its efficiency in handling complex, high-dimensional data. Thus, TopConNMF provides a deeper understanding of complex biological systems by producing stable and interpretable factorization. Its broad applicability across multiple disease manifestations highlights its potential as a valuable tool for advancing omic data analysis and biomarker discovery. Clinical Impact: TopConNMF enables reliable biomarker discovery from limited omic data, supporting early diagnosis, patient stratification, and personalized treatment, thereby bridging computational findings with clinical applications.

Indexed as

Computational BiologyAlgorithmsBiomarkersGene Expression ProfilingHumansBiomarkersFeature representational learningHuntington diseaseNonnegative matrix factorization‘Omic profilesType-2 diabetes

Identifiers

PMID41820508
PMCPMC13106657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.